Table 3.

Differences in CNA between samples with and without clonal heterogeneity (more than 25% differences)

Types of lymphoma	Clonal heterogeneity (−)		Clonal heterogeneity (+)		Detailed in
	Gain	Loss	Gain	Loss
MCL	—	—	6q21, 8q13.3–q24.23†	1p22.1–q12, 5q23.1,§ 7q36.3, 8p23.3–11.21, 9p24.3–q31.1,¶ 17p13.3–11.2††	Figure S2
DLBCL	—	—	19q13.12–.43	9p21.3,¶ 17p13. 2–11. 2††	Figure2
FL	—	—	2p16.1–14, 7p11.1, 7q31.1–.2, ‡ 8q22.1–24.23,† 9q12–34.3,‡ 10p15.3–13, 12p13.33–q21.1, 18p11.21–q23	—	Figure S3
BL	1q44, 12p13.33–q24.33, 15q22.32–15q25.1	—	1q25.2, 3q26.33–29, 13q31.3–32.3, 17q23.1–24.1	6p25.3–22.3, q13–21, 10q23.33–24.1, 11q23.3–25, 14q11.1–32.33,‡‡ 16q24.3, 17p13.3–q12††	Figure S4
MALT	1p36.33–.32, 2q14.3, 3p26.3–q29, 5q31.1, 10p12.31–.1, 18q11.2 -q23	—	13q34, 20p11.22–q12, 22q11.21	7q31.31–q34, 20p12.1	Figure S5
PTCL-NOS	5p15.1	—	7q21.11–q35,‡ 8q24.13–.21,† 9q33.3–34,‡ 16p13.3–11.1, 17q21.2–25.3	2p23.3, q21.3–37.3, 4p16.1–15.2, 5q14.3–34,§ 9p21.3–q31.1,¶ 10q11.1–q23.31, 12p13.1–.13, 13q21.31–34, 14q13.1–32.12,‡‡ 15q23, 17p13.3–11.2††	Figure S6
All lymphomas	—	—	—	9p21.3,¶ 17p13.3–11.2††	Figure S7

Common aberrations more than two lymphomas are indicated in bold with underline.

^†Aberration is found in MCL, FL and PTCL-NOS;

^‡aberration found in FL and PTCL-NOS;

^§aberration found in MCL and PTCL-NOS;

^¶aberration found in MCL, DLBCL and PTCL-NOS;

^††aberration found in MCL, DLBCL, BL and PTCL-NOS;

^‡‡aberration found in BL and PTCL-NOS. —, no region is identified; BL, Burkitt lymphoma; DLBCL, diffuse large B-cell lymphoma; FL, follicular lymphoma; MALT, mucosa-associated lymphoid tissue lymphoma; MCL, mantle cell lymphoma; PTCL-NOS, peripheral T-cell lymphoma, not otherwise specified.